NewsBenzingaMereo BioPharma Group 第三季度每股收益(EPS)为 $(0.01),符合预期,销售额为 80.0 万美元 Mereo BioPharma Group 第三季度每股收益(EPS)为 $(0.01),符合预期,销售额为 80.0 万美元 Benzinga 2026.11.09 13:40 (GMT+0) Open on Benzinga Other news Freedom Broker Maintains Buy on XPeng, Lowers Price Target to $20 Plug Power Shares Slide Toward 52-Week Low Despite New 280-MW Texas Deal Nvidia Vs. Anthropic: Can the AI IPO Challenge Nvidia’s Dominance Across ETFs? Freedom Broker Maintains Buy on Allot, Lowers Price Target to $12.7 Freedom Broker Upgrades M-Tron Industries to Buy, Lowers Price Target to $84 As decision model use skyrockets, is customization is the next frontier?